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INTRODUCTION
Due to the large proportion of people living with chronic neurological impairments, non-
invasive brain stimulation (NIBS) was developed as a potential adjuvant to enhance neurological
rehabilitation. NIBS techniques such as transcranial direct current stimulation (tDCS) and
repetitive transcranial magnetic stimulation (rTMS) have been proposed to temporarily modulate
neural excitability in a given direction based on the type of stimulation used. For example, seminal
studies in tDCS reported that anodal tDCS over the motor cortex (M1) increased corticomotor
excitability, whereas M1 cathodal tDCS decreased corticomotor excitability, for up to an hour
(Nitsche and Paulus, 2001; Nitsche et al., 2003). The polarity dependent changes in corticomotor
excitability were suggested to represent up-regulation or down-regulation of neural plasticity
(Nitsche and Paulus, 2001; Nitsche et al., 2003) and depend on several stimulation parameters
(Woods et al., 2016). When delivered before or during rehabilitation NIBS may increase the
beneficial neuroplastic effects of rehabilitation alone.
Subsequently, the field of NIBS grew rapidly. Many researchers applied tDCS or rTMS to a
wide range of clinical populations and explored many variations in experimental parameters. Most
commonly, researchers opted to use a randomized controlled trial (RCT) study design, allocating
participants to either; real vs. sham stimulation, facilitatory vs. inhibitory stimulation (e.g.,
anodal vs. cathodal tDCS), stimulation alone vs. stimulation with therapy, or some combination
of the above in a multi-arm trial. In addition, NIBS trials have typically used functional
and/or neurophysiological outcomes (such as motor learning tasks or measures of corticomotor
excitability after M1 stimulation) to determine the after-effects of stimulation, often followed up
at multiple time-points to determine the duration of effects. The ease and reported effectiveness
of sham stimulation (e.g., fade in-fade out protocol for tDCS, or sham coil rTMS) (Gandiga et al.,
2006; Mennemeier et al., 2009) allows robust methodological study designs such as double-blinded
cross-over RCTs frequently used in NIBS research.
However, despite the rapid rise of NIBS research over the past 20 years, current evidence has
largely not supported translation into clinical practice, with only rTMS as a treatment for drug-
resistant depression adopted clinically so far (O’Connell et al., 2018; Elsner et al., 2020). One of the
major criticisms of NIBS that likely acts as a barrier to translation is the substantial between-subject
variability observed in response to stimulation (López-Alonso et al., 2014; Wiethoff et al., 2014;
McCambridge et al., 2015). With some causal studies of healthy participants showing that only
half of participants respond to NIBS as expected (López-Alonso et al., 2014; Wiethoff et al., 2014).
Therefore, when investigating group-level changes in outcomes the results are unlikely to show
statistical or clinically meaningful differences and may mask the positive benefits experienced by
some participants. Yet, it is not surprising that substantial between-subject variability exists given
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the lack of precision in current NIBS studies that typically adopt
a “one-size-fits-all” approach to delivery of the intervention.
In the literature, several determinants of NIBS are known
to influence stimulation response, both interventional (e.g.,
type and location of stimulation) and biological factors (e.g.,
skull thickness, brain morphology and neurochemistry) (Filmer
et al., 2019; Hordacre et al., 2021) that should be taken into
consideration when delivering NIBS. Researchers have discussed
the need for individualized or tailored stimulation protocols,
using known determinants of NIBS to guide stimulation
protocols to help address wide-scale variability in responses
(Di Pino et al., 2014; McCambridge et al., 2018; Hordacre
et al., 2021). For example in tDCS research, individualized
stimulation could tailor the stimulation protocol based on clinical
characteristics of the patient (e.g., lesion location, structural
integrity of neural pathways) (Di Pino et al., 2014) or individually
modeled electric fields (Antonenko et al., 2019) or a combination
of many factors including methodological (e.g., dosage and
biological factors) (Hordacre et al., 2021) (Figure 1). Patient-
tailored brain stimulation would be a sensible approach, though
the feasibility of conducting a large-scale RCTwith highly-precise
individualized stimulation protocols for each participant would
be difficult, particularly in a clinical population. Therefore, in
this opinion article, we consider if an alternate methodological
approach to investigating the effectiveness of NIBS in lab-based
or clinical settings would be of interest to the field.
SINGLE-CASE EXPERIMENTAL DESIGNS
To our knowledge, a study design that has not yet been employed
in NIBS research is a single case experimental design (SCED).
SCEDs are clinical trials of an individual (or several individuals
each studied as a single case), in contrast to trials of groups
of participants (Tate and Perdices, 2019). They have also been
called single-system designs, single-subject designs, single-case
research designs, single participant designs, interrupted time-
series designs, and N-of-1 trials. As with many other study
designs, the results of SCEDs can be included in systematic
reviews (Tanious and Onghena, 2020). To establish a causal
relationship between a target behavior and an intervention,
SCEDs have four essential elements: (1) the participant is their
own control, (2) a priori methods are used, (3) the target behavior
is repeatedly measured before, during and after an intervention,
and (4) the intervention is systematically manipulated (Tate and
Perdices, 2019). Inferences about the intervention are then drawn
from the repeated demonstration of the intervention effect on
the outcome. Table 1 shows the four classifications of SCED
designs: (1) withdrawal/reversal designs, (2) multiple-baselines
designs, (3) alternating-treatments designs, and (4) changing-
criterion designs. A range of modifications and combinations
of these four approaches have been used to date (Shadish and
Sullivan, 2011), with some designs better suited to particular
type of research questions (see Table 1). One key appeal of a
SCED is the ability to individualize an intervention to a given
participant, as would be done in many clinical practice settings.
For health research, SCEDs are considered Level 1 evidence
(OCEBM Levels of Evidence Working Group, 2011) and the
methodological quality of SCEDs can be assessed and guided
by the recently developed Single-Case Reporting guideline In





To further elaborate on SCEDs and the potential utility for
NIBS research, we propose an example SCED protocol to
answer the research question “Is motor cortex anodal tDCS
more effective than sham tDCS at increasing corticomotor
excitability in chronic stroke participants?” To answer this
question, a withdrawal multiple treatment design is appropriate
(see Table 1). In this example, an A-B-C-B-C-A design could be
used where A = baseline or follow-up with no stimulation, B
= sham tDCS, and C = real tDCS. This design provides three
opportunities to examine the experimental effect between B and
C. To establish the absolute effectiveness of B or C compared to
baseline, the design would require at least three phase changes
involving A and C, and three involving A and B. This is a
very cumbersome design [e.g., A-B-C-B-C-A-B-A-C-A (Tate and
Perdices, 2019)]. One ethical and practical consideration here is
whether the design should end on an active intervention phase
so that the study ends on a potentially beneficial treatment for
the patient. The appropriate duration of each phase is dependent
on the “wash-out” period needed after stimulation, estimated to
be 1–1.5 h for anodal tDCS (Nitsche and Paulus, 2001) thereby
minimizing possible confounding “alternation effects” (Tate and
Perdices, 2019). Within each phase, at least five measurements
of the outcome measure should be taken (see Figure 1B for
hypothetical data) to account for possible variability (Kratochwill
et al., 2013). In this example, 10 TMS-pulses could be delivered
every 4–5 s at each measurement to provide a total of five average
MEP amplitudes per phase.
Randomization and blinding are important for the internal
validity of a SCED. Randomization can be achieved in some
SCED classifications by randomizing the phases, or randomizing
the onset in a multiple-baseline study. In our A-B-C-B-C-A
example, the sequence of phases is not randomized. However,
blinding could be achieved by concealing the stimulation type
(real, sham) to the participants and the outcome assessors
and not revealing the order of phases or having a separate
researcher administer the intervention that is not involved in
data collection or analysis. For example, sham tDCS protocols
set up the electrodes the same as in real stimulation except the
current is ramped up to provide sensory stimulation on the
scalp and then ramped down again to no stimulation. Some
tDCS machines can also be pre-programmed to do the “fade
in-fade out” protocol without the experimenter’s knowledge or
use a separate experimenter deliver the stimulation. In addition,
blinding during the analysis could be achieved by not disclosing
the phase (baseline, real, sham, follow up) to the statistician
analyzing the data until all analyses are complete.
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FIGURE 1 | (A) Example of individualized transcranial direct current stimulation (tDCS) that could be tested using SCED methodology. (B) Hypothetical data for an
A-B-C-B-C-A design where five measurements are taken in each of the six phases so that three phase changes between B and C can be reported on (e.g., B → C, C
→ B, and B → C again).
Considerations
In terms of reporting on a SCED study, it is important
to thoroughly report the selection criteria, participant
characteristics, setting, outcome measures, equipment,
intervention details, and the procedural fidelity of the
intervention. A thorough description is required for
replication and to maximize the external validity of the
study, for example, researchers may want to repeat the trial
on three or more participants that represent the clinical
population (i.e., young and old, male and female, different
settings etc.).
Detailed descriptions of all phases of the intervention are
required (i.e., baseline, real, sham) in SCED studies. If the study
uses patient-tailored brain stimulation then a comprehensive
description should be given about how stimulation is
individualized (i.e., based on what parameters) so that replication
of the intervention application and how it was individualized
could be achieved in subsequent trials. Reporting how and when
the intervention was delivered as well as the intervention dosage
(e.g., current strength, duration of stimulation, electrode size
and placement etc.) is of particular importance. Similar detail
should be given to describing the sham intervention, for example
the current strength and duration of the tDCS fade in-fade out
protocol (Ambrus et al., 2012).
Analysis
To begin planning a SCED data analysis, it is important to
first determine if changes in level, trend, and/or variability of
the outcome measure are indicative of a treatment effect. For
example, if the outcome measure was corticomotor excitability
assessed with TMS–induced motor evoked potentials (MEP),
then a change in the level of corticomotor excitability (i.e.,
amplitude of the MEPs) with real NIBS compared to sham and
baseline would indicate stimulation was effective. Similarly, if the
outcomewas amotor learning task youmay hypothesize a change
in the trend (i.e., rate of improvement) with real NIBS would
indicate that the treatment was effective. Visual and statistical
analysis supplement each other in SCED studies and need to
be utilized in conjunction (Tate and Perdices, 2019), though
controversy about analysis procedures exist.
The approach selected for visual and statistical analysis is
essential to consider. Kratochwill et al. (2013) includes four
steps in visually evaluating the phases of a SCED study which
can be summarized as: (1) “Is the data stable at baseline?”
(2) “Are there any trends or variability?” (3) “How long until
there is an effect?” and (4) “Did the control work?” Various
techniques exist to visually analyse data in a systematic and
objective manner, including descriptive statistics, level changes,
split-middle trend lines, variability and evaluating trends in each
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TABLE 1 | Classification of SCED designs adapted from Chapter 1 of Tate and Perdices (2019).
Classification Research question NIBS example research
question





What is the effect of systematically
introducing and withdrawing the
intervention on the target behavior?
Does individualized motor
cortex anodal tDCS
compared to sham tDCS
facilitate corticomotor
excitability?
If intervention effects are to be







What is the effect of an intervention
when applied simultaneously, but in a
staggered sequence, to different
participants, or alternatively, different
target behaviors or different settings
for the same individual?
Does cognitive training with
tDCS whether delivered at
home or in clinic improve
cognition in people with
multiple sclerosis?
If (1) the intervention is likely to
produce permanent changes, or (2) it







What is the effectiveness of two or
more interventions (one of which can




inhibitory stimulation of the
motor cortex most effective
at increasing paretic arm
function after stroke?
If two or more interventions can be
provided to the same participant in
rapid alternation
• Comparison phase only
• Comparison phase with initial
baseline




How effective is an intervention at
gradually inducing therapeutic
change in the target behavior?
Is NIBS to the pre-frontal
cortex able to gradually
reduce food cravings in
Bulimia nervosa?
If (1) the intervention is not withdrawn,
(2) the same intervention is applied
across all the subphases, and (3) the
level of target behavior performance
in each intervention subphase can
become the “baseline” against which





phase (Parsonson et al., 1992; Lane and Gast, 2014; Barton
et al., 2018). For statistical analysis methods, detailed guides are
available (Manolov and Solanas Pérez, 2018) because a range of
issues may influence the validity of statistical tests (Parker et al.,
2011; Velicer andMolenaar, 2013; Harrington and Velicer, 2015).
Statistical analyses are valuable (1) when variability appears large
upon visual inspection, (2) when effects of interventions are not
yet well-understood, (3) when small but important changes in
target behaviors cannot be detected by visual analysis, or (4) to
enhance replication studies (Kazdin and Tuma, 1982).
ADVANTAGES AND CHALLENGES
SCEDs are a useful study design to further explore NIBS,
particularly for patient-tailored NIBS protocols. Similar to a RCT,
SCEDs are considered Level 1 evidence for health interventions
(OCEBM Levels of Evidence Working Group, 2011). One
advantage of a SCED over a large-scale RCT is that it is
more cost effective, because it requires fewer participants and
resources. Not requiring large sample sizes to achieve statistical
power may be of particular importance for low-incidence
patient populations that often suffer from being under-powered.
In addition, because SCEDs use an individual as their own
control, outcome measures can be interpreted as absolute values
relative to the participant’s baseline. Interpretation of absolute
values would avoid non-validated normalization procedures
used in some neurophysiological research (e.g., pre-post, pre-
post/post, pre-post/pre+post). Although tailored-interventions
can be used in RCTs, SCEDs are also suitable for patient-
tailored treatments that may involve clinical judgements that are
commonplace in clinical practice. In a SCED study, individual
modifications to the protocol can be extensively explained for
each participant so that replication is possible. Furthermore,
exploring patient-tailored NIBS with a SCED design can also
inform how a tailored intervention could be further tested in a
large-scale RCT.
However, there are some important challenges that should
be considered. A current challenge to SCED research is the
generalizability of findings, particularly for very heterogenous
patient populations (e.g., stroke, dystonia). Replication is
therefore required, though guidance on how many participants
are needed for acceptable replication is lacking. SCED’s can also
be burdensome to participants because they require extensive
data collection. Another challenge is that SCED’s are vulnerable
to plausible rival hypotheses that may explain the outcomes
such as, maturation, regression to the mean and external factors
(Caneiro et al., 2019). Further, there are currently no agreed
upon statistical analysis procedures. Criticism of the subjective
nature of visual inspection, and hence acceptability of SCEDs
as Level 1 evidence by the field, could also be a barrier
to translation.
SUMMARY
In summary, the fundamental aspects of NIBS appear to be
suitable for studies using SCED methodology. This approach
may be a useful avenue to further investigate inter-individual
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variability and more advanced individualized stimulation
protocols. In addition, due to the relative ease and safety
of modulating the independent variable in NIBS research,
NIBS may also be a candidate field to improve and develop
SCED methodology.
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